1,435
Views
20
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Thrombin induces epithelial-mesenchymal transition via PAR-1, PKC, and ERK1/2 pathways in A549 cells

, , &
Pages 336-348 | Received 30 Nov 2012, Accepted 26 Jun 2013, Published online: 06 Aug 2013

REFERENCES

  • Gross TJ, Hunninghake GW: Idiopathic pulmonary fibrosis. N Engl J Med. 2001;345:517–525.
  • Chambers RC: Procoagulant signalling mechanisms in lung inflammation and fibrosis: novel opportunities for pharmacological intervention? Br J Pharmacol. 2008;153(Suppl 1):S367–S378.
  • Chapman HA, Allen CL, Stone OL: Abnormalities in pathways of alveolar fibrin turnover among patients with interstitial lung disease. Am Rev Respir Dis. 1986;133:437–443.
  • Ikeda T, Hirose N, Koto H, Hirano H, Shigematsu N: Fibrin deposition and fibrinolysis in the pathogenesis of pulmonary fibrosis. Nihon Kyobu Shikkan Gakkai Zasshi. 1989;27:448–451.
  • Kotani I, Sato A, Hayakawa H, Urano T, Takada Y, Takada A: Increased procoagulant and antifibrinolytic activities in the lungs with idiopathic pulmonary fibrosis. Thromb Res. 1995;77:493–504.
  • Idell S, Gonzalez K, Bradford H, MacArthur CK, Fein AM, Maunder RJ, Garcia JG, Griffith DE, Weiland J, Martin TR, : Procoagulant activity in bronchoalveolar lavage in the adult respiratory distress syndrome. Contribution of tissue factor associated with factor VII. Am Rev Respir Dis. 1987;136:1466–1474.
  • Marshall R, Bellingan G, Laurent G: The acute respiratory distress syndrome: fibrosis in the fast lane. Thorax. 1998;53:815–817.
  • Hernandez-Rodriguez NA, Cambrey AD, Harrison NK, Chambers RC, Gray AJ, Southcott AM, duBois RM, Black CM, Scully MF, McAnulty RJ, : Role of thrombin in pulmonary fibrosis. Lancet. 1995;346:1071–1073.
  • Tani K, Yasuoka S, Ogushi F, Asada K, Fujisawa K, Ozaki T, Sano N, Ogura T: Thrombin enhances lung fibroblast proliferation in bleomycin-induced pulmonary fibrosis. Am J Respir Cell Mol Biol. 1991;5:34–40.
  • Imokawa S, Sato A, Hayakawa H, Kotani M, Urano T, Takada A: Tissue factor expression and fibrin deposition in the lungs of patients with idiopathic pulmonary fibrosis and systemic sclerosis. Am J Respir Crit Care Med. 1997;156:631–636.
  • Coughlin SR: How the protease thrombin talks to cells. Proc Natl Acad Sci USA. 1999;96:11023–11027.
  • Vu TK, Hung DT, Wheaton VI, Coughlin SR: Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation. Cell. 1991;64:1057–1068.
  • Rasmussen UB, Vouret-Craviari V, Jallat S, Schlesinger Y, Pages G, Pavirani A, Lecocq JP, Pouyssegur J, Van Obberghen-Schilling E: Cdna cloning and expression of a hamster alpha-thrombin receptor coupled to ca2+ mobilization. FEBS Lett. 1991;288:123–128.
  • Howell DC, Goldsack NR, Marshall RP, McAnulty RJ, Starke R, Purdy G, Laurent GJ, Chambers RC: Direct thrombin inhibition reduces lung collagen, accumulation, and connective tissue growth factor mrna levels in bleomycin-induced pulmonary fibrosis. Am J Pathol. 2001;159:1383–1395.
  • Bogatkevich GS, Gustilo E, Oates JC, Feghali-Bostwick C, Harley RA, Silver RM, Ludwicka-Bradley A: Distinct pkc isoforms mediate cell survival and DNA synthesis in thrombin-induced myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2005;288:L190–201.
  • Howell DC, Johns RH, Lasky JA, Shan B, Scotton CJ, Laurent GJ, Chambers RC: Absence of proteinase-activated receptor-1 signaling affords protection from bleomycin-induced lung inflammation and fibrosis. Am J Pathol. 2005;166:1353–1365.
  • Gunther A, Lubke N, Ermert M, Schermuly RT, Weissmann N, Breithecker A, Markart P, Ruppert C, Quanz K, Ermert L, : Prevention of bleomycin-induced lung fibrosis by aerosolization of heparin or urokinase in rabbits. Am J Respir Crit Care Med. 2003;168:1358–1365.
  • Yasui H, Gabazza EC, Tamaki S, Kobayashi T, Hataji O, Yuda H, Shimizu S, Suzuki K, Adachi Y, Taguchi O: Intratracheal administration of activated protein C inhibits bleomycin-induced lung fibrosis in the mouse. Am J Respir Crit Care Med. 2001;163:1660–1668.
  • Hinz B: The myofibroblast: paradigm for a mechanically active cell. J Biomech. 2010;43:146–155.
  • Leask A, Abraham DJ: The role of connective tissue growth factor, a multifunctional matricellular protein, in fibroblast biology. Biochem Cell Biol. 2003;81:355–363.
  • Scotton CJ, Chambers RC: Molecular targets in pulmonary fibrosis: the myofibroblast in focus. Chest. 2007;132:1311–1321.
  • Selman M, Pardo A, Kaminski N: Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs? PLoS Med. 2008;5:e62.
  • Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006;7:131–142.
  • Bucala R, Spiegel LA, Chesney J, Hogan M, Cerami A: Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med. 1994;1:71–81.
  • Hong KM, Belperio JA, Keane MP, Burdick MD, Strieter RM: Differentiation of human circulating fibrocytes as mediated by transforming growth factor-beta and peroxisome proliferator-activated receptor gamma. J Biol Chem. 2007;282:22910–22920.
  • Schmidt M, Sun G, Stacey MA, Mori L, Mattoli S: Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol. 2003;171:380–389.
  • Bogatkevich GS, Tourkina E, Silver RM, Ludwicka-Bradley A: Thrombin differentiates normal lung fibroblasts to a myofibroblast phenotype via the proteolytically activated receptor-1 and a protein kinase c-dependent pathway. J Biol Chem. 2001;276:45184–45192.
  • Bogatkevich GS, Tourkina E, Abrams CS, Harley RA, Silver RM, Ludwicka-Bradley A: Contractile activity and smooth muscle alpha-actin organization in thrombin-induced human lung myofibroblasts. Am J Physiol Lung Cell Mol Physiol. 2003;285:L334–343.
  • Tourkina E, Gooz P, Pannu J, Bonner M, Scholz D, Hacker S, Silver RM, Trojanowska M, Hoffman S: Opposing effects of protein kinase c alpha and protein kinase cepsilon on collagen expression by human lung fibroblasts are mediated via mek/erk and caveolin-1 signaling. J Biol Chem. 2005;280:13879–13887.
  • Foster KA, Oster CG, Mayer MM, Avery ML, Audus KL: Characterization of the a549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res. 1998;243:359–366.
  • Nangaku M: Mechanisms of tubulointerstitial injury in the kidney: final common pathways to end-stage renal failure. Intern Med. 2004;43:9–17.
  • Kim KK, Kugler MC, Wolters PJ, Robillard L, Galvez MG, Brumwell AN, Sheppard D, Chapman HA: Alveolar epithelial cell mesenchymal transition develops in vivo during pulmonary fibrosis and is regulated by the extracellular matrix. Proc Natl Acad Sci USA. 2006;103:13180–13185.
  • Choi SW, Park HY, Rubeiz NG, Sachs D, Gilchrest BA: Protein kinase c-alpha levels are inversely associated with growth rate in cultured human dermal fibroblasts. J Dermatol Sci. 1998;18:54–63.
  • Luzina IG, Highsmith K, Pochetuhen K, Nacu N, Rao JN, Atamas SP: Pkc alpha mediates ccl18-stimulated collagen production in pulmonary fibroblasts. Am J Respir Cell Mol Biol. 2006;35:298–305.
  • Siflinger-Birnboim A, Johnson A: Protein kinase c modulates pulmonary endothelial permeability: a paradigm for acute lung injury. Am J Physiol Lung Cell Mol Physiol. 2003;284:L435–451.
  • Hollenberg MD, Saifeddine M, al-Ani B, Kawabata A: Proteinase-activated receptors: structural requirements for activity, receptor cross-reactivity, and receptor selectivity of receptor-activating peptides. Can J Physiol Pharmacol. 1997;75:832–841.
  • Kawabata A, Saifeddine M, Al-Ani B, Leblond L, Hollenberg MD: Evaluation of proteinase-activated receptor-1 (PAR1) agonists and antagonists using a cultured cell receptor desensitization assay: activation of par2 by par1-targeted ligands. J Pharmacol Exp Ther. 1999;288:358–370.
  • Kawao N, Nagataki M, Nagasawa K, Kubo S, Cushing K, Wada T, Sekiguchi F, Ichida S, Hollenberg MD, MacNaughton WK, : Signal transduction for proteinase-activated receptor-2-triggered prostaglandin e2 formation in human lung epithelial cells. J Pharmacol Exp Ther. 2005;315:576–589.
  • Wang H, Wen S, Bunnett NW, Leduc R, Hollenberg MD, MacNaughton WK: Proteinase-activated receptor-2 induces cyclooxygenase-2 expression through beta-catenin and cyclic amp-response element-binding protein. J Biol Chem. 2008;283:809–815.
  • Zhang A, Wang MH, Dong Z, Yang T: Prostaglandin e2 is a potent inhibitor of epithelial-to-mesenchymal transition: interaction with hepatocyte growth factor. Am J Physiol Renal Physiol. 2006;291:F1323–F1331.
  • Jimenez SA, Gaidarova S, Saitta B, Sandorfi N, Herrich DJ, Rosenbloom JC, Kucich U, Abrams WR, Rosenbloom J: Role of protein kinase c-delta in the regulation of collagen gene expression in scleroderma fibroblasts. J Clin Invest. 2001;108:1395–1403.
  • Zhang L, Keane MP, Zhu LX, Sharma S, Rozengurt E, Strieter RM, Dubinett SM, Huang M: Interleukin-7 and transforming growth factor-beta play counter-regulatory roles in protein kinase c-delta-dependent control of fibroblast collagen synthesis in pulmonary fibrosis. J Biol Chem. 2004;279:28315–28319.
  • Fang Q, Liu X, Abe S, Kobayashi T, Wang XQ, Kohyama T, Hashimoto M, Wyatt T, Rennard SI: Thrombin induces collagen gel contraction partially through par1 activation and pkc-epsilon. Eur Respir J. 2004;24:918–924.
  • Trejo J, Connolly AJ, Coughlin SR: The cloned thrombin receptor is necessary and sufficient for activation of mitogen-activated protein kinase and mitogenesis in mouse lung fibroblasts. Loss of responses in fibroblasts from receptor knockout mice. J Biol Chem. 1996;271:21536–21541.
  • Deng X, Mercer PF, Scotton CJ, Gilchrist A, Chambers RC: Thrombin induces fibroblast ccl2/je production and release via coupling of par1 to galphaq and cooperation between erk1/2 and rho kinase signaling pathways. Mol Biol Cell. 2008;19:2520–2533.
  • Antoniou KM, Margaritopoulos GA, Soufla G, Symvoulakis E, Vassalou E, Lymbouridou R, Samara KD, Kappou D, Spandidos DA, Siafakas NM: Expression analysis of akt and mapk signaling pathways in lung tissue of patients with idiopathic pulmonary fibrosis (ipf). J Recept Signal Transduct Res. 2010;30:262–269.
  • Zhou SY, Xiao W, Pan XJ, Zhu MX, Yang ZH, Zheng CY: Thrombin promotes human lung fibroblasts to proliferate via nadph oxidase/reactive oxygen species/extracellular regulated kinase signaling pathway. Chin Med J (Engl). 2010;123:2432–2439.
  • Junn E, Lee KN, Ju HR, Han SH, Im JY, Kang HS, Lee TH, Bae YS, Ha KS, Lee ZW, : Requirement of hydrogen peroxide generation in tgf-beta 1 signal transduction in human lung fibroblast cells: involvement of hydrogen peroxide and ca2+ in tgf-beta 1-induced il-6 expression. J Immunol. 2000;165:2190–2197.
  • Torres-Gonzalez E, Bueno M, Tanaka A, Krug LT, Cheng DS, Polosukhin VV, Sorescu D, Lawson WE, Blackwell TS, Rojas M, : Role of endoplasmic reticulum stress in age-related susceptibility to lung fibrosis. Am J Respir Cell Mol Biol. 2012;46:748–756.
  • Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ: Collagen i promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling. Am J Respir Cell Mol Biol. 2008;38:95–104.
  • Lee JM, Dedhar S, Kalluri R, Thompson EW: The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol. 2006;172:973–981.
  • Zavadil J, Bottinger EP: Tgf-beta and epithelial-to-mesenchymal transitions. Oncogene. 2005;24:5764–5774.
  • Kirkland JG, Cottrell GS, Bunnett NW, Corvera CU: Agonists of protease-activated receptors 1 and 2 stimulate electrolyte secretion from mouse gallbladder. Am J Physiol Gastrointest Liver Physiol. 2007;293:G335–G346.
  • Ando S, Otani H, Yagi Y, Kawai K, Araki H, Fukuhara S, Inagaki C: Proteinase-activated receptor 4 stimulation-induced epithelial-mesenchymal transition in alveolar epithelial cells. Respir Res. 2007;8:31.